Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumours

Clinical Endocrinology

Volumn 47, Issue 5, 1997, Pages 523-528

  Chung, Daniel C ^a,b   Smith, Alison P ^a   Louis, David N ^a   Graeme Cook, Fiona ^a   Warshaw, Andrew L ^a   Arnold, Andrew ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE LOCUS; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULINOMA; MALE; PANCREAS ISLET CELL TUMOR; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0030725466     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2861110.x     Document Type: Article

References (32)

1. Bale, A.E., Norton, J.A., Wong, E.L., Fryburg, J.S., Maton, P.N., Oldfield, E.H., Streeten, E., Aurbach, G.D., Brandi, M.L., Friedman, E., Speigel, A.M., Taggart, R.T. & Marx, S.J. (1991) Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. Cancer Research, 51, 1154-1157.
2. Benedict, W.F., Xu, H.-J., Hu, S.-X. & Takahashi, R. (1990) Role of the retinoblastoma gene in the initiation and progression of human cancer. Journal of Clinical Investigation, 85, 988-993.
3. Boynton, R.F., Huang, Y., Blount, P.L., Reid, B.J., Raskind, W.H., Haggitt, R.C., Newkirk, C., Resau, J.H., Yin, J., McDaniel, T. & Meltzer, S.J. (1991) Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Research, 51, 5766-5769.
4. Caron, H., van Sluis, P., de Kraker, J., Bokkerink, J., Egeler, M., Laureys, G., Slater, R., Westerveld, A., Voute, P.A. & Versteeg, R. (1996) Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. New England Journal of Medicine, 334, 225-230.
5. Chandrasekharappa, S.C., Guru, S.C., Manickam, P., Olufemi, S.-E., Collins, F.S., Emmert-Buck, M.R., Debelenko, L.V., Zhyang, Z., Lubensky, I.A., Liotta, L.A., Crabtree, J.S., Wang, Y., Roe, B.A., Weiseman, J., Bogusky, M.S., Agarwal, S.K., Rester, M.B., Kim, Y.S., Heppner, C., Dong, Q., Spiegel, A.M., Burns, A.L. & Marx, S.J. (1997) Positional cloning of the gene for multiple endocrine neoplasia type 1. Science, 276, 404-407.
6. Cryns, V.L., Alexander, J.M., Klibanski, A. & Arnold, A. (1993) The retinoblastoma gene in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 77, 644-646.
7. Cryns, V., Thor, A., Xu. H.-J., Hu, S.-X., Wierman, M., Vickery, A., Benedict, W. & Arnold, A. (1994) Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. New England Journal of Medicine, 330, 757-761.
8. DeCaprio, J.A., Ludlow, J.W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C. & Livingston, D.M. (1989) The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell, 58, 1085-1095.
9. Dotzenrath, C., Teh, B.T., Farnebo, F., Cupisti, K., Svensson, A., Toell, A., Goretzki, P. & Larsson, C. (1996) Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? Journal of Clinical Endocrinology and Metabolism, 81, 3194-3196.
10. Eubanks, P.J., Sawicki, M.P., Samara, G.J., Gatti, R., Nakamura, Y., Tsao, D., Johnson, C., Hurwitz, M., Wan, Y.-J. & Passaro, E. (1994) Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation. American Journal of Surgery, 167, 180-185.
11. Evers, B.M., Rady, P.L., Sandoval, K., Arany, I., Tyring, S.K., Sanchez, R.L., Nealon, W.H., Townsend, C.M. & Thompson, J.C. (1994) Gastrinomas demonstrate amplification of the HER-2/neu proto-oncogene. Annals of Surgery, 219, 596-604.
12. Harbour, J.W., Lai, S.L., Whang-Peng, J., Gazdar, A.F., Minna, J.D. & Kaye, F.J. (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science, 241, 353-357.
13. Harvey, M., Vogel, H., Lee, E., Bradley, A. & Donehower, L. (1995) Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Research, 55, 1146-1151.
14. Hruban, R.H., van Mansfeld, A.O.M., Offerhaus, G.J.A., van Weering, D.H.J., Allison, D.C., Goodman, S.N., Kensler, T.W., Bose, K.K., Cameron, J.L. & Bos, J.L. (1993) K-ras oncogene activation in adenocarcinomas of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. American Journal of Pathology, 143, 545-554.
15. Iwamura, Y., Futagawa, T., Kaneko, M., Nakagawa, K., Kawai, K., Yamashita, K., Nakamura, T. & Hayashi, H. (1992) Co-deletions of the retinoblastoma gene and wilms' tumor gene and rearrangement of the Krev-1 gene in a human insulinoma. Japanese Journal of Clinical Oncology, 22, 6-9.
16. Jen, J., Kim, H., Piantadosi, S., Liu, Z.-F., Levin, R.C., Sistonen, P., Kinzler, K.W., Vogelstein, B. & Hamilton, S.R. (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. New England Journal of Medicine, 331, 213-221.
17. Kloppel, G., Hofler, H. & Heitz, P.U. (1993) Pancreatic endocrine tumors in man. In Diagnostic Histopathohgy of Neuroendocrine Tumors (ed. J.M. Polak), pp. 91-121. Churchill Livingstone, Edinburgh.
18. Kloppel, G., In't Veld, P.A., Stamm, B. & Heitz, P.U. (1991) The endocrine pancreas. In Functional Endocrine Pathology (ed. K. Kovacs and S.L. Asa), pp. 396. Blackwell Scientific Publications, Boston.
19. Lee, W., Shew, J., Hong, F.D., Sery, T.W., Donoso, L.A., Young, L., Bookstein, R. & Lee, E.Y.P. (1987) The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature, 329, 642-645.
20. Miyamoto, H., Shuin, T., Torigoe, S., Iwasaki, Y. & Kubota, Y. (1995) Retinoblastoma gene mutations in primary human bladder cancer. British Journal of Cancer, 71, 831-835.
21. Newcomb, E.W., Thomas, A., Selkirk, A., Lee, S.Y. & Potmesil, M. (1995) Frequent homozygous deletions of D13So218, on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivation. Cancer Research, 55, 2044-2047.
22. Pavelic, K., Hrascan, R., Kapitanovic, S., Karapandza, N., Vranes, Z., Belicza, M., Kruslin, B. & Cabrijan, T. (1995) Multiple genetic-alterations in malignant metastatic insulinomas. Journal of Pathology, 177, 395-400.
23. Pearce, S.H.S., Trump, D., Wooding, C., Sheppard, M.N., Clayton, R.N. & Thakker, R.V. (1996) Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours. Clinical Endocrinology, 45, 195-200.
24. Pei, L., Melmed, S., Scheithauer, B., Kovacs, K., Benedict, W.F. & Prager, D. (1995) Frequent loss of heterozygosity at the retino-blastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Research, 55, 1613-1616.
25. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) Molecular cloning: a laboratory manual. 2nd edn. pp. 9.16-9.19, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
26. Sieracki, J., Marshall, R.B. & Horn, R.C. (1960) Tumors of the pancreatic islets. Cancer, 13, 347-357.
27. Williams, B.O., Remington, L., Albert, D.M., Mukai, S., Bronson, R.T. & Jacks, T. (1994) Cooperative tumorigenic effects of germline mutations in Rh and p53. Nature Genetics, 7, 480-484.
28. Wright, O.K. & Manos, M.M. (1990) Sample preparation from paraffin-embedded tissues. In PCR Protocols: a Guide to Methods and Applications (ed. M. A. Innis, D. H. Gelfand, J. J. Sninsky and T. J. White), pp. 153-158. Academic Press, San Diego.
29. Xu, H.J., Cairns, P., Hu, S.X., Knowles, M.A. & Benedict, W.F. (1993) Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. International Journal of Cancer, 53, 781-784.
30. Yashiro, T., Fulton, N., Hara, H., Yasuda, K., Montag, A., Yashiro, N., Straus, F., Ito, K., Aiyoshi, Y. & Kaplan, E. (1993) Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery, 114, 758-764.
31. Yoshimoto, K., Iwahana, H., Fukuda, A., Sano, T., Saito, S. & Itakura, M. (1992) Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Research, 52, 5061-5064.
32. Zhang, X., Xu, H.J., Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S.X., Benedict, W.F. & Sekiya, T. (1994) Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Research, 54, 4177-4182.